Caricamento...
A case–control study of quadrivalent human papillomavirus vaccine-associated autoimmune adverse events
GARDASIL (Merck & Co., Inc., Whitehouse Station, NJ, USA) is a quadrivalent human papillomavirus (HPV4) vaccine. An epidemiological study was undertaken to evaluate concerns about the potential for HPV4 vaccination to induce serious autoimmune adverse events (SAAEs). The vaccine adverse event re...
Salvato in:
| Pubblicato in: | Clin Rheumatol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer London
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4475239/ https://ncbi.nlm.nih.gov/pubmed/25535199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10067-014-2846-1 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|